News

Barchart. com
barchart. com > story > news > 2432540 > postoperative-pain-pipeline-expands-as-40-companies-driving-innovation-in-the-therapeutics-delveinsight

Postoperative Pain Pipeline Expands as 40+ Companies Driving Innovation in the Therapeutics | Delve Insight

2+ week, 1+ day ago  (111+ words) Key Takeaways from Postoperative Pain Pipeline Report Uncover critical updates on therapeutic innovations and their potential impact on Postoperative Pain patients @ Postoperative Pain Unmet Needs Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route…...

Symbols: nasdaq:ensc
Barchart. com
barchart. com > story > news > 2282857 > osteoarthritis-market-gains-momentum-with-expanding-pipeline-and-investment-potential-by-2036-delveinsight-merck-kgaa-peptinov-lg-chem-akan-bioscience-biotissue-inc-eupraxia-pharma

Osteoarthritis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 " Delve Insight | Merck KGa A, Peptinov, LG Chem, Akan Bioscience, Bio Tissue, Inc. , Eupraxia Pharma

3+ week, 3+ day ago  (959+ words) Get a Free sample for the Osteoarthritis Market Forecast, Size & Share Analysis Report: Some of the key facts of the Osteoarthritis Market Report: The Osteoarthritis market size was valued at approximately USD 32. 5 billion in 2025 and is projected to reach nearly…...

Symbols: arpa-h
Barchart. com
barchart. com > story > news > 2158856 > opioid-use-disorder-therapeutics-pipeline-strengthens-as-10-biopharma-companies-advance-targeted-treatment-strategies-delveinsight

Opioid Use Disorder Therapeutics Pipeline Strengthens as 10+ Biopharma Companies Advance Targeted Treatment Strategies | Delve Insight

4+ week, 2+ day ago  (232+ words) Key Takeaways from the Opioid Use Disorder Pipeline Report Want to know which companies are leading innovation in Opioid Use Disorder? @ Opioid Use Disorder Clinical Trials Assessment The Opioid Use Disorder Pipeline Report provides a disease overview, pipeline scenario, and…...

Symbols: nasdaq:indv
Barchart. com
barchart. com > story > news > 1647496 > axial-spondyloarthritis-market-pharma-pipeline-fuels-rapid-expansion-by-2034-delveinsight-janssen-pharma-pfizer-ucb-biopharma-celgene-inmagene-biopharma-galapago-kyowa-kirin-co-eli-lilly

Axial Spondyloarthritis Market: Pharma Pipeline Fuels Rapid Expansion by 2034 " Delve Insight | Janssen Pharma, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharma, Galapago, Kyowa Kirin Co, Eli Lilly

1+ mon, 3+ week ago  (611+ words) Some of the key facts of the Axial Spondyloarthritis Market Report: The Axial Spondyloarthritis market size is anticipated to grow with a significant CAGR during the study period (2020-2034). In September 2024, UCB, a global biopharmaceutical company, announced that the U. S. Food and…...

Symbols: btc-usd
Barchart. com
barchart. com > story > news > 1647499 > osteoarthritis-market-to-evolve-rapidly-over-the-next-decade-by-2034-delveinsight-observe-merck-kgaa-peptinov-lg-chem-akan-bioscience-biotissue-inc-eupraxia-pharmaceuticals-inc-olipass-corp

Osteoarthritis Market to Evolve Rapidly Over the Next Decade by 2034, Delve Insight Observe | Merck KGa A, Peptinov, LG Chem, Akan Bioscience, Bio Tissue, Inc. , Eupraxia Pharmaceuticals Inc. , Oli Pass Corp

1+ mon, 3+ week ago  (855+ words) Some of the key facts of the Osteoarthritis Market Report: In 2023, the Osteoarthritis market size was the largest in the United States among the 7 MM, valued at around USD 19, 000 million, and is projected to grow further by 2034 at a CAGR…...

Symbols: arpa-h
Barchart. com
barchart. com > story > news > 1306567 > therawolf-neuro-balm-review-a-natural-breakthrough-for-nerve-pain-relief

Thera Wolf Neuro Balm Review: A Natural Breakthrough for Nerve Pain Relief?

2+ mon, 1+ week ago  (613+ words) In this in-depth review, we'll explore how Thera Wolf Neuro Balm works, its ingredients, benefits, pricing, real customer experiences, and whether it's truly worth trying. Thera Wolf Neuro Balm is a topical pain relief formula specifically developed to help soothe…...

Symbols: nasdaq:elva,tsx:elva
Barchart. com
barchart. com > story > news > 1195770 > petoteco-launches-zenbelly-hemp-free-calming-chews-for-dogs-and-cats-targeting-the-gut-brain-axis

Petoteco Launches Zen Belly: Hemp-Free Calming Chews for Dogs and Cats Targeting the Gut-Brain Axis

2+ mon, 2+ week ago  (188+ words) While the US market offers many hemp-based calming treats, pet parents frequently express concerns about long-term side effects and extreme lethargy. Petoteco provides a safer alternative for managing separation anxiety, thunderstorm phobia, travel stress, and vet visits for both felines…...

Symbols: cbd
Barchart. com
barchart. com > story > news > 1099342 > back-restore-review-2026-can-this-nonsurgical-solution-really-relieve-back-pain

Back Restore Review (2026): Can This Non-Surgical Solution Really Relieve Back Pain?

2+ mon, 3+ week ago  (1188+ words) Back pain is one of the most common issues people deal with today, especially if you sit for long hours, have poor posture, or struggle with sciatica. That's where Back Restore comes in. It's being marketed as a non-surgical, drug-free…...

Symbols: nasdaq:spp,spp,iaotb
Barchart. com
barchart. com > story > news > 954987 > osteoarthritis-clinical-trial-pipeline-advances-as-100-companies-develop-110-novel-therapies-across-all-clinical-stages-finds-delveinsight-biosplice-therapeutics-regeneron-pharmaceuticals

Osteoarthritis Clinical Trial Pipeline Advances as 100+ Companies Develop 110+ Novel Therapies Across All Clinical Stages, Finds Delve Insight | Biosplice Therapeutics, Regeneron Pharmaceuticals

3+ mon, 1+ day ago  (382+ words) Key Takeaways from the Osteoarthritis Pipeline Report On March 23, 2026, Enlivex received authorization from the FDA to proceed with its investigational new drug application (IND) for Allocetra, an immunotherapy for moderate-to-severe age-related symptomatic primary knee osteoarthritis. This clearance enables the company…...

Symbols: oa
Barchart. com
barchart. com > story > news > 929985 > osteoarthritis-pipeline-witnesses-strong-expansion-with-100-companies-advancing-110-innovative-therapies-delveinsight

Osteoarthritis Pipeline Witnesses Strong Expansion with 100+ Companies Advancing 110+ Innovative Therapies | Delve Insight

3+ mon, 2+ day ago  (221+ words) Key Highlights from the Osteoarthritis Pipeline Report Gain deeper insights into clinical trials and pipeline progress: Osteoarthritis Clinical Trials and Studies Osteoarthritis (OA) is the most prevalent form of arthritis and is often referred to as degenerative joint disease or…...

Symbols: oa